EP0272091A3
Delivery vehicles with amphiphile-associated active ingredient
Abstract
Delivery vehicles comprising an outer biocompatible encapsulating layer, an inner amphiphilic active ingredient-associated layer and an active ingredient are described. The delivery vehicles are biocompatible and are capable of solubilizing the active ingredient for invivo delivery to bodily tissue or other bodily systems. Uses include nuclear magnetic resonance imaging and therapeutic drug delivery.
Term
Term ended
Projected expiry passed 15 December 2007, 18.8 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0186616A1 | Cites | European Patent Office (EPO) | X | Search report |
| EP0198765A2 | Cites | European Patent Office (EPO) | X | Search report |
| US4208294A | Cites | United States of America | Y | Search report |
| WO8702364A1 | Cites | World Intellectual Property Organization (WIPO) | XP | Search report |
| J.C.S. CHEM. COMM., no. 22, 15th November 1979, pages 1067-1068; S. MANN et al.: "Location of biological compartments by high resolution N.M.R. spectroscopy and electron microscopy using magnetite-containing vesicles" | Non-patent | – | – | Search report |
29 members in 12 offices; this record represents the family
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 942093 | United States of America | – | |
| 94209386 | United States of America | A |
Members29
| Document | Office | Kind | |
|---|---|---|---|
| DK651187D0 | Denmark | D0 | |
| NO875194D0 | Norway | D0 | |
| IE873387L | Ireland | L | |
| AU8249487A | Australia | A | |
| DK651187A | Denmark | A | |
| NO875194L | Norway | L | |
| EP0272091A2 | European Patent Office (EPO) | A2 | |
| KR880007065A | Republic of Korea | A | |
| KR880008502A | Republic of Korea | A | |
| JPS63233915A | Japan | A | |
| EP0272091A3This record | European Patent Office (EPO) | A3 | |
| AU608264B2 | Australia | B2 | |
| NO171583B | Norway | B | |
| NO171583C | Norway | C | |
| EP0272091B1 | European Patent Office (EPO) | B1 | |
| AT89717T | Austria | T | |
| ATE89717T1 | Austria | T1 | |
| CA1319614C | Canada | C | |
| DE3786005D1 | Germany | D1 | |
| DE3786005T2 | Germany | T2 | |
| US5320906A | United States of America | A | |
| IE60562B1 | Ireland | B1 | |
| ES2056832T3 | Spain | T3 | |
| KR950015052B1 | Republic of Korea | B1 | |
| JP2677572B2 | Japan | B2 | |
| EP0272091B2 | European Patent Office (EPO) | B2 | |
| DE3786005T3 | Germany | T3 | |
| ES2056832T5 | Spain | T5 | |
| DK175531B1 | Denmark | B1 |
70 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Nl: ceased due to reaching the maximum lifetime of a patentCeasedNLV7 | NLV7 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Patent modifiedDC2A | DC2A | ES | |
| Nl: receipt of modified translations in the netherlands language after an opposition procedureOppositionNLR3 | NLR3 | EP | |
| Fr: translation filed ** decision concerning oppositionOppositionET3 | ET3 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: decision of oppositionOppositionNLR2 | NLR2 | EP | |
| Scope or validity of the patent modifiedMAINTIEN DU BREVET DONT L'ETENDUE A ETE MODIFIEEAEN | AEN | CH | |
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Opposition filed (corrected)OppositionR26 | R26 | EP | |
| Interlocutory decision in oppositionOppositionORIGINAL CODE: EPIDOS IDOPPLAW | PLAW | EP | |
| Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB | PLAB | EP | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOS REFNOAPAE | APAE | EP | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| Interlocutory decision in oppositionOppositionORIGINAL CODE: EPIDOS IDOPPLAW | PLAW | EP | |
| Transmission of propertyTP | TP | FR | |
| Nl: assignments of ep-patentsNLS | NLS | EP | |
| Nl: assignments of ep-patentsNLS | NLS | EP | |
| Transfer of patentPC2A | PC2A | ES | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Nl: modifications (of names), taken from the european patent patent bulletinNLT2 | NLT2 | EP | |
| AssignmentPUE | PUE | CH | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Lu: last paid annual feeEPTA | EPTA | EP | |
| Validation in greece3008695FG4A | FG4A | GR | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0272091
- Application
- 87311040
Titles3
- English
- Delivery vehicles with amphiphile-associated active ingredient
- French
- Véhicule pour la libération contenant un agent actif associé à une substance amphiphile
- German
- Träger zur Freisetzung mit einem an eine amphiphile Substanz gekoppelten Wirkstoff
Classification
- CPC, 4
- A61K49/1812
- H02M1/08
- A61K9/1277
- H02M1/06
- IPC, 7
- A61K9 10
- A61K9 107
- A61K9 127
- A61K9 50
- A61K47 48
- A61K49 00
- A61K49 18
Designated states13
- Contracting states, 13
- Austria
- Belgium
- Switzerland
- Germany
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden